AGN argenica therapeutics limited

Ann: Argenica to Progress Clinical Development in TBI, page-3

  1. 311 Posts.
    lightbulb Created with Sketch. 171
    Fantastic result, I don't feel the market's got a good handle on what this could mean for AGN at this stage.

    Hopefully we'll see Liz presenting these results somewhere soon, but in the meantime there's this video of the TechKnow roadshow in Sydney recorded before today's announcement, where she says this in relation to its potential therapeutic use for Traumatic Brain Injury...

    "The TBI data is starting to look really, really compelling. So again, there are no drugs, no therapeutic drugs on the market that can protect against brain injury in TBI. 69 million people globally suffer a TBI that warrants them going to a hospital every year. So you think the 5 billion dollar stroke market is big? The TBI therapeutic market is absolutely phenomenal."

    AGN's presentation starts at about the 42 minute mark and the TBI/ferret discussion starts at 57 minutes in.

    https://www.youtube.com/live/NV_SDAojHKU?si=9031TzcO69p-82hX
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
68.5¢
Change
-0.005(0.72%)
Mkt cap ! $87.99M
Open High Low Value Volume
70.0¢ 70.0¢ 68.5¢ $48.95K 70.83K

Buyers (Bids)

No. Vol. Price($)
2 14807 68.5¢
 

Sellers (Offers)

Price($) Vol. No.
69.0¢ 29902 1
View Market Depth
Last trade - 15.29pm 07/08/2025 (20 minute delay) ?
AGN (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.